We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.

AusPAR: Asfotase alfa (rch)

Australian Public Assessment Report

AusPAR

AusPAR: Asfotase alfa (rch) [PDF, 1.44 MB]

AusPAR: Asfotase alfa (rch) [DOCX, 1.65 MB]

Attachment: Product Information: Asfotase alfa (rch) [PDF, 252.09 KB]

Attachment: Product Information: Asfotase alfa (rch) [DOCX, 151.38 KB]

Attachment: Extract from Clinical Evaluation Report: Asfotase alfa (rch) [PDF, 3.39 MB]

Attachment: Extract from Clinical Evaluation Report: Asfotase alfa (rch) [DOCX, 4.96 MB]

Device/Product Name

Strensiq

Active ingredients

Asfotase alfa (rch)

AusPAR Date

1 July 2016

Published

5 July 2016

Submission Number

PM-2014-03845-1-3

Submission Type

New chemical entity

Decision

Approved

Product types

Prescription medicines